Virtu Financial LLC Voyager Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$6.94 - $13.99 $193,313 - $389,691	27,855 New	27,855 $319,000
Q2 2022 Aug 09, 2022	SELL	$4.82 - $10.09 $88,895 - $186,089	-18,443 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.75 - $9.44 $22,387 - $76,851	8,141 Added 79.02%	18,443 $141,000
Q4 2021 Feb 17, 2022	BUY	$2.47 - $5.55 $25,445 - $57,176	10,302 New	10,302 $28,000
Q4 2017 Feb 09, 2018	SELL	$12.26 - $25.88 $284,076 - $599,665	-23,171 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$8.37 - $20.59 $193,941 - $477,090	23,171	23,171 $0

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.